AstraZeneca’s deadly deception: Heart drug Brilinta exposed as ineffective, increasing …

In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.  For more than a decade, ticagrelor (Brilinta in the US and Brilique in Europe) has …

Millions of patients at high risk of a fatal heart attack could be taking a drug that may not even be effective, top doctors have warned.  Anti-clotting pill ticagrelor was approved for use on the NHS in 2011 after trials claimed it could prevent one in …

Key Takeaways Eli Lilly will acquire Verve for roughly $1 billion Verve is developing a one-time gene-editing treatment for heart disease The company's lead drug, Verve-102, targets a gene linked to high cholesterol WEDNESDAY, June 18, 2025 (HealthDay …

… pharmacologyprotein kinase G activation mechanismsrepurposing heart drugs for growth disorderssignaling pathways in …

… .” Viagra was invented as a heart drug in the 1980s before it …

… stress on the heart. Certain heart medications can also heighten the body …

… we found The multibillion dollar heart drug ticagrelor (Brilinta, Brilique) goes generic …

… becomes loopy from mixing his heart medication with alcohol at the meeting …